Unfortunately for its shareholders, the Dorsavi Ltd (ASX: DVL) share price has continued its disappointing run.
During trade today the motion analysis technology company’s shares fell as much as 16% to a 52-week low of 26 cents.
Its shares have since rebounded, but are still down over 46% since the turn of the year. Not even a new contract win has been enough to shift sentiment.
Last week the company announced a three-year deal with Kieser Australia worth approximately $150,000.
The deal will see the recently launched ViMove 2 rolled out across Kieser’s network of nine centres in Melbourne and Sydney.
ViMove is dorsaVi’s wearable sensor technology used by medical and physiotherapy practices to assess and monitor movement.
The company also provides similar technology to the elite sports market and to the OHS market.
This company’s dividend is almost the stuff of legends. Since it started paying dividends in 2007, it has increased its payout to shareholders every single year, a run that includes 21 consecutive dividend increases.
Based on the last 12-months of dividends, its shares are currently offering a fully-franked 4.8% yield, which grosses up to almost 7% when those franking credits are included.
Discover the name of this “new breed” of blue chip along with 2 others in our new FREE report "The Motley Fool’s Top 3 Blue Chips Stocks For 2017."
Click here to receive your copy.
Motley Fool contributor Motley Fool Staff has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.